|
Market Closed -
Nasdaq
16:00:00 2026-09-24 EDT
|
5-day change | 1st Jan Change | ||
| 34.83 USD | +0.23% |
|
+1.25% | +13.08% |
| 09-24 | AbbVie Says Health Canada Issues Notice of Compliance for EPKINLY in Follicular Lymphoma | MT |
| 09-24 | Hansa Biopharma brings in two new board members | FW |
Main competitors
| Consensus | Analysts' target price evolution (4 months) | Analysts' recommendations evolution (4 months) | Financial estimates divergence | Analysts' Target price divergence | Average Target P. | Objective/dr gap | Nbr of analysts | ||
|---|---|---|---|---|---|---|---|---|---|
 | 187.07 | +11.38% | 18 | ||||||
| 1,176.01 | +23.5% | 15 | ||||||
| 199.55 | +68.62% | 22 | ||||||
| 102.96 | +19.14% | 20 | ||||||
| 2,303.24 | +0.49% | 16 | ||||||
| 1,397.26 | +18.92% | 8 | ||||||
| 53.69 | -5.36% | 16 | ||||||
| 21.57 | +76.86% | 13 | ||||||
| 680.82 | +32.71% | 17 | ||||||
| 110 | +64.28% | 12 | ||||||
| 12.75 | +47.74% | 4 | ||||||
| 109.9 | +67% | 20 | ||||||
| 109 | +92.94% | 9 | ||||||
| 120.08 | +36.19% | 13 | ||||||
| 228.89 | +35.7% | 9 | ||||||
| - | - | - | - | - | ||||
| 446.89 | +13.14% | 19 | ||||||
| 155 | +72.37% | 12 | ||||||
| 70.38 | +41.17% | 16 | ||||||
| Average | 415.84 | +39.82% | 14 | ||||||
| Weighted average by Cap. | 547.48 | +29.92% | 16 |
- Stock Market
- Stocks
- GMAB Stock
- GMAB Stock
- Sector Genmab A/S
- Sector consensus
Select your edition
All financial news and data tailored to specific country editions
